Zusammenfassung
Die Lungentransplantation hat in den letzten 15 Jahren Eingang in die Therapie der terminalen respiratorischen Insuffizienz bei cystischer Fibrose gefunden. Die ersten erfolgreichen Herz-Lungentransplantationen wurden nach der Einführung von Ciclosporin A in den frühen Achtzigerjahren in Stanford bei Patienten mit primärer pulmonaler Hypertonie durchgeführt. Später entwickelte man in Toronto die Technik der Einzellungentransplantation für Patienten mit Lungenfibrose, woraus das Verfahren der bilateralen sequentiellen Doppellungentransplantation entstand. Seit den frühen Neunzigerjahren werden auch Lungenlappen von verstorbenen oder von lebenden Spendern transplan-tiert. Die kumulative Gesamtzahl der transplantier-ten Doppellungen, Einzellungen, Herz-Lungen und Lungenlappen liegt Anfang des Jahres 2000 weltweit bei 14000. In den USA weisen eine Reihe von Zentren eine Transplantationsfrequenz von mehr als 10 Lungen pro Jahr auf. Im deutschsprachigen Raum sind wor allem Hannover, Wien, Berlin , München, Zürich, Homburg and Kiel aktiv. Jährlich werden gegenwärttig in Deutschland allein zwischen 100 und 150 Lungen transplantiert
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
American Society for Transplant Physicians (ASTP)/American Thoracic Society (ATS)/European Respiratory Society (ERS)/International Society for Heart and Lung Transplantation (ISHLT) (1998) International guidelines for the selection of lung transplant candidates. Am J Respir Crit Care Med 158 (1): 335–339
Arcasoy SM, Kotloff RM (1999) Lung transplantation. N Engl J Med 340 (14): 1081–1091
Aris RM, Neuringer IP, Weiner MA, Egan TM, Ontjes D (1996) Severe osteoporosis before and after lung transplantation. Chest 109 (5): 1176–1183
Aris RM, Gilligan PH, Neuringer IP, Gott KK, Rea J, Yankaskas JR (1997) The effect of panresistent bacteria in cystic fibrosis patients on lung transplant outcome. Am J Respir Crit Care Med 155 (5):1699–1704
Balfour-Lynn IM, Martin I, Whitehead BF, Elliott MJ, de Leval MR (1997) Heart-lung transplantation for patients under 10 with cystic fibrosis. Arch Dis Child 76 (1): 38–40
Barr ML, Schenkel FA, Cohen RG, Barbers RG, Fuller CB, Hagen JA, Wells WJ, Starnes VA (1998) Recipient and donor outcomes in living related and unrelated lobar transplantation. Transplant Proc 30 (5): 2261–2263
Berkowitz N, Schulman LL, McGregor C, Markowitz D (1995) Gastroparesis after lung transplantation: Potential role in postoperative respiratory complications. Chest 108: 1602–1607
Boucek MM, Novick RJ, Bennett LE, Fiol B, Keck BM, Hosenpud JD (1998) The Registry of the international Society of Heart and Lung Transplantation: Second official pediatric report — 1998. J Heart Lung Transplant 17 (12): 1141–1160
Busschbach JJ, Horikx PE, van den Bosch JM, Brutel-de-la-Reviere A, de Charro FT (1994) Measuring the quality of life before and after bilateral lung transplantation in patients with cystic fibrosis. Chest 105 (3):911–917
Caine N, Sharples LD, Dennis C, Higenbottam TW, Wallwork J (1996) Measurement of health-related quality of life before and after heart-lung transplantation. J Heart Lung Transplant 15:1047–1058
Cooper JD, Billingham M, Egan T et al. (1993) A working formulation for the standardization of nomenclature and for clinical Staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12:713–716
Couetil JP, Tolan MJ, Loulmet DF, Guinvarch A, Chevalier PG, Achkar A, Birmbaum P, Carpentier AF (1997) Pulmonary bipartitioning and lobar transplantation: a new approach to donor organ shortage. J Thorac Cardiovasc Surg 113 (3):529–537
Date H, Lynch JP, Sundaresan S, Patterson GA, Trulock EP (1998) The impact of cytolytic therapy on bronchilitis obliterans Syndrome. J Heart Lung Transplant 17: 869–875
DeMeester J, Smits JMA, Persijn GG, Haverich A (1999) Lung Transplant waiting list: Differential outcome of type of end-stage lung disease, one year after registration. J Heart Lung Transplant 18:563–571
Doershuk CF, Stern RC (1999) Timing of referral for lung transplantation for cystic fibrosis: overemphasis on FEV1 may adversely affect overall survival. Chest 115 (3): 782–787
Egan TM (1998) Surgical options for lung transplantation in patients with cystic fibrosis In: Franco KL, Putnam JB (eds): Advanced therapy in thoracic surgery. B.C. Decker Inc., Hamilton London Saint Louis, pp 366–376
Eurotransplant Jahresberichte 1984–1998, Leiden, Niederlande
Fitz-Simmons SC (1998) US Cystic Fibrosis Foundation, Patient Registry 1997 Annual Data Report, Bethesda, Maryland
Gleeson JG, du Plessis AJ, Barnes PD, Riviello JJ (1998) Cyclosporin A acute encephalopathy and seizure Syndrome in childhood: clinical features and risk of seizure recurrence. J Child Neurol 13 (7): 336–344
Goldstein LS, Haug MT, Perl J, Perl MK, Maurer JR, Arroliga AC, Mehta AC, Kirby T, Higgins B, Stillwell PC (1998) Central nervous System complications after lung transplantation. J Heart Lung Transplant 17 (2): 185–191
Götz I, Labenbacher I, Eichler I, Wojnarowski C, Götz M (1997) Health-independent lung transplantation information of parents of children with cystic fibrosis. Transplantation 64 (5): 742–747
Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J (1998) Bronchiolitis obliterans Syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17:1255–1263
Hanto DW (1995) Classification of Epstein-Barr Virus-Associated Posttransplant Lymphoproliferative Diseases: Implications for Understanding Their Pathogenesis and Developing Rational Treatment Strategies. Annu Rev Med 46: 381–394
Horning NR, Lynch JP, Sundaresan SR, Patterson GA, Trulock EP (1998) Tacrolimus therapy for persistent or re-current acute rejection after lung transplantation. J Heart Lung Transplant 17:761–767
Hosenpud JD, Bennett LE, Keck BM, Fiol B, Novick RJ (1997) The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report —1997. J Heart Lung Transplant 16 (7):691–712
Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick RJ (1998) The Registry of the International Society for Heart and Lung Transplantation: Fifteenth official report — 1998. J Heart Lung Transplant 17 (7): 656–668
Hosenpud JD, Bennett LE, Keck BM, Edwards EB, Novick RJ (1998) Effect of diagnosis on survival benefit of lung trans-plantation for end-stage lung disease. Lancet 351:24–27
Hummel M (1995) Akutes Nierenversagen nach Herztransplantation. In: Hetzer R (Hrsg) Fortschritte der Herz-, Thorax- und Gefäßchirurgie. Steinkopff, Darmstadt
Kanj SS, Tapson V, Davis RD, Madden J, Browning I (1997) Infections in patients with cystic fibrosis following lung transplantation. Chest 112 (4):924–930
Kerem E, Reisman J, Corey M, Canny GJ, Levison H (1992) Prediction of mortality in patients with cystic fibrosis. N Engl J Med 326 (18): 1187–1191
Klima LD, Kowdley KV, Lewis SL, Wood DE, Aitken ML (1997) Succesful lung transplantation in spite of cystic fibrosis-assiciated liver disease: a case series. J Heart Lung Transplant 16:934–938
Mendeloff EN, Huddleston CB, Mallory GB, Trulock EP, Cohen AH, Sweet CS Lynch H, Sundaresan S, Cooper JD, Patterson GA (1998) Pediatric and adult lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 115 (2): 404–414
Norgaard MA, Andersen CB, Pettersson G (1998) Does bronchial artery revascularization influence results concerning bronchiolitis obliterans Syndrome and/or obliterative bronchiolitis after lung transplantation? Eur J CardiothoracSurg l4(3):311–318
Novick RJ, Stitt LW, Al-Kattan K, Klepetko W, Schäfers HJ, Khaghani A, Haresty RL, Patterson GA, Yacoub MH (1998) Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry. Ann Thorac Surg 65 (1): 227–234
Nunley D, Dauber J, Iacono A, Keenan R, Zeevi A, Cornwell R, Love R, Meyer K, Soergel P, Peterson K (1999) Unopposed neutrophil elastase in bronchoalveolar lavage from transplant reeipients with cystic fibrosis. Am J Respir Crit Care Med 159 (1):258–261
Nunley DR, Ohori P, Grgurich WF, Iacono AT, Williams PA, Keenan RJ, Dauber JH (1998) Pulmonary aspergillosis in cystic fibrosis lung transplant recipients. Chest 114 (5): 1321–1329
Oelberg DA, Systrom DM, Markowitz DH, Zorb SL, Wright C, Wain JC, Ginns LC (1998) Exercise Performance in cystic fibrosis before and after bilateral lung transplantation. J Heart Lung Transplant 17:1104–1112
Paditz E (Hrsg) (1997) Nasale Maskenbeatmung im Kindes- und Erwachsenenalter. Springer, Berlin Heidelberg New York Tokio
Reitz BA, Poston RS (1999) Heart-Lung Transplantation. In: Franco KL, Verrier ED (eds) Advanced therapy in cardiac surgery. B.C. Decker Inc., Hamilton London Saint Louis, pp 491–501
Schäfers HJ, Hausen B, Wahlers T, Fieguth HG, Jurmann M, Borst HG (1995) Retransplantation of the lung. A Single center experience. Eur J Cardiothorac Surg 9:291–295
Schulman LL, Weinberg AD, McGregor C, Galantowicz ME, Suciu-Foca NM, Itescu S (1998) Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med 157: 1833–1837
Smith AL, Cohen M, Ramsey BW (1999) Pharmacotherapy. In: Yankaskas JR, Knowles MR (eds) Cystic fibrosis in adults. Lippin-Raven, New York Philadelphia
Smith PC, Slaughter MS, Petty MG, Shumway SJ, Kshettry VR, Bolaman RM (1995) Abdominal complications after lung transplantation. J Heart Lung Transplant 14:44–51
Snee GI, Bennetts K, Bartolo J, Lewey B, Griffiths A et al. (1998) Body mass index as a predictor of survival in adults with cystic fibrosis referred for lung transplantation. J Heart Lung Transplant 17:1097–1103
Trulock EP (1997) Lung transplantation. Am J Respir Crit Care Med 155 (3):789–818
Tsang VT, Johnston A, Heritier F, Leaver N, Hodson ME, Yacoub M (1994) Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis. Effects of pancreatic enzymes and ranitidine. Eur J Clin Pharmacol 46 (3): 261–265
Wiebe K, Wahlers T, Harringer W, von der Hardt H, Fabel H, Haverich A (1998) Lung transplantation for cystic fibrosis — a Single center experience over 8 years. Eur J Cardiothorac Surg 14:191–196
Wood A, Higenbottam T, Jackson M, Scott J, Stewart S, Wallwork J (1989) Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis 140 (6): 1645–1649
Yankaskas JR, Mallory GB (1998) Lung transplantation in cystic fibrosis: consensus Conference Statement. Chest 113 (l):217–226
Yousem SA, Berry GJ, Cagle PT, Chamberlain D, Husain AN, Hruban RH, Marchevsky A, Ohori NP, Ritter J, Steward S, Tazelaar HD (1996) Revision of the 1990 Working Formulation for the Classification of Pulmonary Allograft Rejection: Lung Rejection Study Group. J Heart Lung Transplant 15:1–15
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Paul, K., Hetzer, R. (2001). Lungen- und Herz-Lungentransplantation. In: Reinhardt, D., Götz, M., Kraemer, R., Schöni, M.H. (eds) Cystische Fibrose. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56796-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-642-56796-4_14
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63172-6
Online ISBN: 978-3-642-56796-4
eBook Packages: Springer Book Archive